Lindahl assisted Newbury Pharmaceuticals AB with listing
Lindahl assisted Newbury Pharmaceuticals AB with listing of the company's shares on Nasdaq First North Growth Market.
In connection with the listing, a new share issue of approximately SEK 50 million was carried out for the general public in Sweden, Norway, Denmark and Finland as well as for institutional investors. There was a great deal of interest in the offer, which was oversubscribed. The first day of trading is 4 February.
Lindahl acted as legal advisor to Newbury in connection with the listing and raising capital and the team consisted mainly of Johan Herrström and Pontus Söderberg.
About our client Newbury
Newbury provides prescription medicines to patients and healthcare providers in the Scandinavian market. The company focuses on speciality medicines and proprietary brands with particular focus on oncology, rare diseases and neurology.
Do you want to know more? Contact:
Johan Herrström
Managing Partner Malmö | AdvokatPontus Söderberg
Senior Associate | AdvokatCarousel items
-
News articles
12/4/2025
Lindahl ranked in Chambers FinTech Guide 2026
Lindahl has been ranked in the Chambers FinTech Guide 2026: Sweden. Both the firm and partner Anna Wahlbom are ranked in Band 4.
-
Knowledge
12/3/2025
Proposal for new Cybersecurity Act - implementation of the NIS2 directive in Swedish law
An overview of the new NIS2 inquiry, what it entails and how you can prepare your business in view of the new regulation
-
Cases and transactions
12/2/2025
Lindahl has represented Trelleborg Port in successful arbitration dispute against Rover
Lindahl has represented Trelleborgs Hamn AB in a comprehensive arbitration dispute against Rover Maritime SL concerning the contract for the expansion of ferry berths 13 and 14 in Trelleborg port. The arbitration award represented a significant su...
-
Portraits
11/7/2025
Capital markets and public M&A at Lindahl: Expertise, working environment and range
Read about how Monica Lagercrantz and Lindahl's experts in capital markets and public M&A support companies with stock exchange listings, new share issues and ongoing advice – with expertise, range and a working environment that makes a difference.
-
Read more news and insights?
